Skip to Content

NVR RIC (Kisqali 200 mg)

Generic Name: ribociclib

Pill with imprint NVR RIC is Purple, Round and has been identified as Kisqali 200 mg. It is supplied by Novartis Pharmaceuticals Corporation.

Kisqali is used in the treatment of breast cancer, metastatic; breast cancer and belongs to the drug class CDK 4/6 inhibitors. Kisqali 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for NVR RIC

Kisqali

Generic Name
ribociclib
Imprint
NVR RIC
Strength
200 mg
Color
Purple
Size
11.00 mm
Shape
Round
Availability
Prescription only
Drug Class
CDK 4/6 inhibitors
CSA Schedule
Not a controlled drug
Labeler / Supplier
Novartis Pharmaceuticals Corporation
National Drug Code (NDC)
00078-0874
Inactive Ingredients
silicon dioxide, crospovidone, magnesium stearate, microcrystalline cellulose, ferrosoferric oxide, ferric oxide red, soya lecithin, magnesium silicate, titanium dioxide, xanthan gum

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "NVR RIC"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.